AAAAAA

   
Results: 1-18 |
Results: 18
LIPOSOMES AS DRUG-DELIVERY SYSTEM - A STRATEGIC APPROACH FOR THE TREATMENT OF HIV-INFECTION
Authors: DESORMEAUX A BERGERON MG
Citation: A. Desormeaux et Mg. Bergeron, LIPOSOMES AS DRUG-DELIVERY SYSTEM - A STRATEGIC APPROACH FOR THE TREATMENT OF HIV-INFECTION, Journal of drug targeting, 6(1), 1998, pp. 1-15
INTRACELLULAR AND SERUM STABILITY OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE - EFFECT OF LIPID-COMPOSITION
Authors: MAKABIPANZU B GOURDE P DESORMEAUX A BERGERON MG
Citation: B. Makabipanzu et al., INTRACELLULAR AND SERUM STABILITY OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE - EFFECT OF LIPID-COMPOSITION, Cellular and molecular biology, 44(2), 1998, pp. 277-284
ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL
Authors: OMAR RF HARVIE P GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL, Toxicology and applied pharmacology, 143(1), 1997, pp. 140-151
ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL
Authors: HARVIE P OMAR RF DUSSERRE N DESORMEAUX A GOURDE P TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 451-461
COMPARATIVE PHARMACOKINETICS, DISTRIBUTIONS IN TISSUE, AND INTERACTIONS WITH BLOOD PROTEINS OF CONVENTIONAL AND STERICALLY STABILIZED LIPOSOMES CONTAINING 2',3'-DIDEOXYINOSINE
Authors: HARVIE P DESORMEAUX A BERGERON MC TREMBLAY M BEAUCHAMP D POULIN L BERGERON MG
Citation: P. Harvie et al., COMPARATIVE PHARMACOKINETICS, DISTRIBUTIONS IN TISSUE, AND INTERACTIONS WITH BLOOD PROTEINS OF CONVENTIONAL AND STERICALLY STABILIZED LIPOSOMES CONTAINING 2',3'-DIDEOXYINOSINE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 225-229
IN-VIVO TOXICITY OF FOSCARNET AND ZIDOVUDINE GIVEN ALONE OR IN COMBINATION
Authors: OMAR RF GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., IN-VIVO TOXICITY OF FOSCARNET AND ZIDOVUDINE GIVEN ALONE OR IN COMBINATION, Toxicology and applied pharmacology, 139(2), 1996, pp. 324-332
RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL
Authors: HARVIE P OMAR RF DUSSERRE N LANSAC N DESORMEAUX A GOURDE P SIMARD M TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 1009-1017
DETERMINATION OF THE SECONDARY STRUCTURE AND CONFORMATION OF PUROINDOLINES BY INFRARED AND RAMAN-SPECTROSCOPY
Authors: BIHAN TL BLOCHET JE DESORMEAUX A MARION D PEZOLET M
Citation: Tl. Bihan et al., DETERMINATION OF THE SECONDARY STRUCTURE AND CONFORMATION OF PUROINDOLINES BY INFRARED AND RAMAN-SPECTROSCOPY, Biochemistry, 35(39), 1996, pp. 12712-12722
UPTAKE AND BINDING OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE BY RAW-264.7 CELLS - A 3-STEP PROCESS
Authors: MAKABIPANZU B LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG
Citation: B. Makabipanzu et al., UPTAKE AND BINDING OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE BY RAW-264.7 CELLS - A 3-STEP PROCESS, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 227-235
TARGETING HIV WITH LIPOSOME-ENCAPSULATED ANTIVIRALS
Authors: DESORMEAUX A BERGERON MG
Citation: A. Desormeaux et Mg. Bergeron, TARGETING HIV WITH LIPOSOME-ENCAPSULATED ANTIVIRALS, Zentralblatt fur Bakteriologie, 282(3), 1995, pp. 225-231
LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS
Authors: DUSSERRE N LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG
Citation: N. Dusserre et al., LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS, Journal of cellular biochemistry, 1995, pp. 177-177
ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS
Authors: DUSSERRE N LESSARD C PAQUETTE N PERRON S POULIN L TREMBLAY M BEAUCHAMP D DESORMEAUX A BERGERON MG
Citation: N. Dusserre et al., ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS, AIDS, 9(8), 1995, pp. 833-841
LYMPHOID-TISSUES TARGETING OF LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE
Authors: HARVIE P DESORMEAUX A GAGNE N TREMBLAY M POULIN L BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., LYMPHOID-TISSUES TARGETING OF LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE, AIDS, 9(7), 1995, pp. 701-707
LIPOSOMAL ENCAPSULATION OF FOSCARNET PROTECTS AGAINST HYPOCALCEMIA INDUCED BY FREE FOSCARNET
Authors: OMAR RF DUSSERRE N DESORMEAUX A POULIN L TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., LIPOSOMAL ENCAPSULATION OF FOSCARNET PROTECTS AGAINST HYPOCALCEMIA INDUCED BY FREE FOSCARNET, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1973-1978
COMPARISON OF CELLULAR ACCUMULATION, TISSUE DISTRIBUTION, AND ANTI-HIV ACTIVITY OF FREE AND LIPOSOMAL 2',3'-DIDEOXYCYTIDINE
Authors: MAKABIPANZU B LESSARD C PERRON S DESORMEAUX A TREMBLAY M POULIN L BEAUCHAMP D BERGERON MG
Citation: B. Makabipanzu et al., COMPARISON OF CELLULAR ACCUMULATION, TISSUE DISTRIBUTION, AND ANTI-HIV ACTIVITY OF FREE AND LIPOSOMAL 2',3'-DIDEOXYCYTIDINE, AIDS research and human retroviruses, 10(11), 1994, pp. 1463-1470
ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE
Authors: DESORMEAUX A HARVIE P PERRON S MAKABIPANZU B BEAUCHAMP D TREMBLAY M POULIN L BERGERON MG
Citation: A. Desormeaux et al., ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE, AIDS, 8(11), 1994, pp. 1545-1553
ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE
Authors: DESORMEAUX A HARVIE P PERRON S MAKABIPANZU B BEAUCHAMP D TREMBLAY M POULIN L BERGERON MG
Citation: A. Desormeaux et al., ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE, AIDS, 8(11), 1994, pp. 1545-1553
PHOTOVOLTAIC AND ELECTRICAL-PROPERTIES OF AL LANGMUIR-BLODGETT FILMS/AG SANDWICH CELLS INCORPORATING EITHER CHLOROPHYLL-A, CHLOROPHYLL-B, OR ZINC PORPHYRIN DERIVATIVE/
Authors: DESORMEAUX A MAX JJ LEBLANC RM
Citation: A. Desormeaux et al., PHOTOVOLTAIC AND ELECTRICAL-PROPERTIES OF AL LANGMUIR-BLODGETT FILMS/AG SANDWICH CELLS INCORPORATING EITHER CHLOROPHYLL-A, CHLOROPHYLL-B, OR ZINC PORPHYRIN DERIVATIVE/, Journal of physical chemistry, 97(25), 1993, pp. 6670-6678
Risultati: 1-18 |